Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Investor Relations Company (TIRC) was a boutique strategic communications and investor relations consultancy based in Chicago, Illinois. The firm specialized in providing comprehensive IR services to small-cap and mid-cap companies, with a significant focus on the healthcare, life sciences, and technology sectors. TIRC's core offerings included financial media relations, analyst and investor outreach, corporate positioning, and crisis management for emerging growth companies. In 2011, the company was acquired by Dresner Corporate Services (DCS), a subsidiary of Dresner Partners, to bolster DCS's capabilities in the small-cap market. The firm was widely recognized for its long-standing expertise and its active role in the financial communications landscape for the biopharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Investor Relations Company.